Commonwealth Equity Services’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.73M | Buy |
78,488
+375
| +0.5% | +$19.8K | 0.01% | 1548 |
|
|
2025
Q4 | $4.1M | Buy |
78,113
+9,016
| +13% | +$540K | 0.01% | 1469 |
|
|
2025
Q3 | $4.48M | Buy |
69,097
+6,523
| +10% | +$374K | 0.01% | 1428 |
|
|
2025
Q2 | $3.04M | Sell |
62,574
-12,308
| -16% | -$476K | ﹤0.01% | 1682 |
|
|
2025
Q1 | $2.55M | Buy |
74,882
+6,268
| +9% | +$266K | ﹤0.01% | 1740 |
|
|
2024
Q4 | $2.7M | Buy |
68,614
+2,206
| +3% | +$104K | ﹤0.01% | 1660 |
|
|
2024
Q3 | $3.12M | Buy |
66,408
+4,849
| +8% | +$246K | ﹤0.01% | 1553 |
|
|
2024
Q2 | $3.33M | Buy |
61,559
+7,560
| +14% | +$437K | 0.01% | 1455 |
|
|
2024
Q1 | $3.68M | Buy |
53,999
+7,383
| +16% | +$529K | 0.01% | 1369 |
|
|
2023
Q4 | $2.92M | Buy |
46,616
+6,593
| +16% | +$364K | 0.01% | 1449 |
|
|
2023
Q3 | $1.82M | Sell |
40,023
-1,038
| -3% | -$53.6K | ﹤0.01% | 1671 |
|
|
2023
Q2 | $2.31M | Buy |
41,061
+720
| +2% | +$40.9K | ﹤0.01% | 1531 |
|
|
2023
Q1 | $1.82K | Sell |
40,341
-10,743
| -21% | -$522K | ﹤0.01% | 1621 |
|
|
2022
Q4 | $2.08M | Sell |
51,084
-56,244
| -52% | -$2.98M | 0.01% | 1473 |
|
|
2022
Q3 | $7.01M | Buy |
107,328
+60,830
| +131% | +$4.41M | 0.02% | 737 |
|
|
2022
Q2 | $2.83M | Buy |
46,498
+3,384
| +8% | +$199K | 0.01% | 1211 |
|
|
2022
Q1 | $2.71M | Buy |
43,114
+7,731
| +22% | +$485K | 0.01% | 1307 |
|
|
2021
Q4 | $2.68M | Sell |
35,383
-3,010
| -8% | -$263K | 0.01% | 1300 |
|
|
2021
Q3 | $4.3M | Buy |
38,393
+3,378
| +10% | +$424K | 0.01% | 952 |
|
|
2021
Q2 | $5.67M | Buy |
35,015
+4,875
| +16% | +$593K | 0.01% | 800 |
|
|
2021
Q1 | $3.67M | Buy |
30,140
+2,275
| +8% | +$344K | 0.01% | 942 |
|
|
2020
Q4 | $4.27M | Buy |
27,865
+3,147
| +13% | +$372K | 0.01% | 805 |
|
|
2020
Q3 | $2.07M | Sell |
24,718
-257
| -1% | -$22.8K | 0.01% | 1081 |
|
|
2020
Q2 | $1.83M | Sell |
24,975
-19,064
| -43% | -$1.11M | 0.01% | 1077 |
|
|
2020
Q1 | $1.87M | Buy |
44,039
+13,507
| +44% | +$697K | 0.01% | 929 |
|
|
2019
Q4 | $1.86M | Buy |
30,532
+12,331
| +68% | +$673K | 0.01% | 1075 |
|
|
2019
Q3 | $746K | Buy |
18,201
+386
| +2% | +$18.4K | ﹤0.01% | 1541 |
|
|
2019
Q2 | $839K | Buy |
17,815
+986
| +6% | +$39.4K | ﹤0.01% | 1455 |
|
|
2019
Q1 | $601K | Buy |
16,829
+4,088
| +32% | +$141K | ﹤0.01% | 1617 |
|
|
2018
Q4 | $364K | Sell |
12,741
-577
| -4% | -$20.1K | ﹤0.01% | 1873 |
|
|
2018
Q3 | $590K | Buy |
13,318
+945
| +8% | +$49.5K | ﹤0.01% | 1678 |
|
|
2018
Q2 | $727K | Buy |
12,373
+6,600
| +114% | +$376K | ﹤0.01% | 1487 |
|
|
2018
Q1 | $263K | Buy |
+5,773
| New | +$238K | ﹤0.01% | 2165 |
|
Other funds holding CRSP
AIM
OAG
GP
SOCM
